6 step-down subsidiaries of Alembic Pharma dissolves
Vadodara: Alembic Pharma has informed in a BSE filing that six step-down subsidiaries of the Company have been dissolved/ in the process of dissolution.
The companies are Okner Realty LLC, Alembic Labs LLC, Alnova Pharmaceuticals SA, Dahlia Therapeutics SA, Genius LLC, Alembic Mami SpA
It may be further noted that none of the above Company was operational.
Medical Dialogues team had earlier reported that the Company had received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC).
Alembic Pharmaceuticals is engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical products. Founded in 1907 and headquartered in Vadodara, Gujarat, Alembic specializes in generic drugs, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. The company has a global presence, with operations in over 75 countries, including the U.S., Europe, and emerging markets. Alembic is known for its medicines across therapeutic segments such as cardiovascular, anti-infective, pain management, and oncology.
Read also: Alembic Pharma gets USFDA nod to Diltiazem Hydrochloride ER Capsules to treat hypertension
